Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Healthtrust
Boehringer Ingelheim
UBS
QuintilesIMS
Harvard Business School
Cerilliant
Citi
Argus Health

Generated: April 23, 2018

DrugPatentWatch Database Preview

ONCOVIN Drug Profile

« Back to Dashboard

When do Oncovin patents expire, and when can generic versions of Oncovin launch?

Oncovin is a drug marketed by Lilly and is included in one NDA.

The generic ingredient in ONCOVIN is vincristine sulfate. There are thirteen drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the vincristine sulfate profile page.
Drug patent expirations by year for ONCOVIN
Medical Subject Heading (MeSH) Categories for ONCOVIN
Synonyms for ONCOVIN
(2ALPHA,2'BETA,3ALPHA,4ALPHA,5BETA,19BETA)-22-OXOVINCALEUKOBLASTINE SULFATE (1:1)
068V782
2068-78-2
22-OXOVINACLEUKOBLASTINE SULFATE
22-OXOVINCALEUKO-BLASTINE SULFATE
22-oxovincaleukoblastine sulfate
22-Oxovincaleukoblastine sulfate salt
AB0105888
AB48730
AC1L6O8Q
AI3-52944
AK206276
AKOS015895862
Alkaloid extracted from Vinca rosea Linn
Ambap2068-78-2
AQTQHPDCURKLKT-JKDPCDLQSA-N
C13974
C46H56N4O10.H2O4S
CCRIS 2583
CHEBI:79401
CHEMBL501867
D02197
DTXSID8044331
EINECS 218-190-0
I06-1238
KB-276095
Kyocristine
l)-6-formyl-5-hydroxy-8-methoxy-3a,3a1,4,5,5a,6,11,12-octahydro-1H-indolizino[8,1-cd]carbazole-5-carboxylate sulfate
LCR
Leuocristine sulfate (1:1)
Leurocristine
Leurocristine sulfate
Leurocristine sulfate (1:1)
Leurocristine sulfate (1:1) (salt)
Leurocristine sulfate salt
Leurocristine, sulfate
Leurocristine, sulfate (1:1) (salt)
Lilly 37231
LS-87932
Marqibo (TN)
METHYL (1R,9R,10S,11R,12R,19R)-11-(ACETYLOXY)-12-ETHYL-4-[(13S,15S,17S)-17-ETHYL-17-HYDROXY-13-(METHOXYCARBONYL)-1,11-DIAZATETRACYCLO[13.3.1.0?,(1)(2).0?,(1)?]NONADECA-4(12),5(10),6,8-TETRAEN-13-YL]-8-FORMYL-10-HYDROXY-5-METH
methyl (3aR,3a1R,4R,5S,5aR,10bR)-4-acetoxy-3a-ethyl-9-((3S,5S,7S,9S)-5-ethyl-5-hydroxy-9-(methoxycarbonyl)-1,4,5,6,7,8,9,10-octahydro-2H-3,7-methano[1]azacycloundecino[5,4-b]indol-9-yl)-6-formyl-5-hydroxy-8-methoxy-3a,3a1,4,5
MFCD08706469
MLS002702994
MolPort-006-069-042
NSC 67574
NSC-67574
NSC67574
Oncovin (Lilly)
Oncovin (TN)
Onkovin
PL050118
SCHEMBL3710
VCR
VCR sulfate
VCR SULFATE SALT
VCR, LEUKOCRISTINE SULFATE
Vincaleukoblastine, 22-oxo-, sulfate (1:1) (salt)
Vincasar (TN)
Vincasar PFS
Vincrex
Vincrex (TN)
Vincrisitine Sulfate
Vincristine sulfate
Vincristine sulfate (JP17/USP)
Vincristine sulfate [USAN:JAN]
vincristine sulfate liposomes
Vincristine Sulfate PFS
Vincristine sulfate salt
Vincristine sulphate
Vincristine, sulfate
Vincristinsulfat [German]
Vincrisul
Z-3315

US Patents and Regulatory Information for ONCOVIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lilly ONCOVIN vincristine sulfate INJECTABLE;INJECTION 014103-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Lilly ONCOVIN vincristine sulfate INJECTABLE;INJECTION 014103-003 Mar 7, 1984 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Lilly ONCOVIN vincristine sulfate INJECTABLE;INJECTION 014103-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Moodys
Covington
US Army
Julphar
Fuji
Teva
Citi
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.